GCANRx Announces Approval of Phase II Clinical Trial to Treat Autism Related Spectrum Disorders
BALTIMORE, July 05, 2023 -- Greater Cannabis Company, Inc. a publicly traded biopharmaceutical company pioneering development of next generation therapeutics is pleased to announce that it has...
Source: marketscreener.com